NIT Warangal Biotechnology cutoff 2023
Every published counselling, quota, category and gender profile for this exact offering.
Comparable round trend
CSAB · OS quota · OPEN · Gender-Neutral
Lower is better. Missing rounds remain gaps.
- R1: opening 32,742; closing 35,121.
- R2: opening 35,949; closing 35,949.
Seat-pool profiles
Rounds are kept separate within each exact rank list.
| Profile | Rounds | Latest round | Opening | Closing |
|---|---|---|---|---|
| CSAB · OS quota · OPEN · Gender-Neutral | 2 | Round 2 | 35,949 | 35,949 |
| CSAB · OS quota · EWS · Gender-Neutral | 2 | Round 2 | 45,219 | 45,219 |
| CSAB · HS quota · OBC-NCL · Gender-Neutral | 2 | Round 2 | 52,722 | 52,722 |
| CSAB · HS quota · OPEN · Gender-NeutralOne published round | 1 | Round 1 | 42,243 | 42,756 |
| CSAB · OS quota · OBC-NCL · Gender-NeutralOne published round | 1 | Round 1 | 39,367 | 42,457 |
| CSAB · OS quota · OPEN (PwD) · Gender-NeutralOne published round | 1 | Round 1 | 5,00,894 | 5,00,894 |
| CSAB · OS quota · SC · Gender-NeutralOne published round | 1 | Round 1 | 1,48,313 | 1,48,313 |
| CSAB · OS quota · ST · Gender-NeutralOne published round | 1 | Round 1 | 1,53,955 | 1,53,955 |
| CSAB · HS quota · EWS · Gender-NeutralOne published round | 1 | Round 1 | 52,695 | 56,505 |
| CSAB · HS quota · SC · Gender-NeutralOne published round | 1 | Round 1 | 1,01,430 | 1,36,942 |
| CSAB · HS quota · ST · Gender-NeutralOne published round | 1 | Round 1 | 1,63,128 | 1,63,128 |
| CSAB · OS quota · EWS · Female-onlyOne published round | 1 | Round 1 | 49,356 | 49,356 |
| CSAB · OS quota · OPEN (PwD) · Female-onlyOne published round | 1 | Round 1 | 8,77,968 | 8,77,968 |
| CSAB · HS quota · EWS · Female-onlyOne published round | 1 | Round 1 | 59,775 | 59,775 |
Other years
Source records
Publisher records used for this exact page.
- CSAB 2023 opening and closing ranks, Round 1, NITadmissions.nic.in
- CSAB 2023 opening and closing ranks, Round 2, NITadmissions.nic.in
DEETNUTS is independent of the counselling authorities and colleges listed. Verify admission decisions on the applicable official portal. Source access does not grant reuse rights; see data & licensing.